pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jun 9·1 min read
save

K Health expands AI chatbot from symptom checker to hospital use

Jun 9, 2026·read at Endpoints ↗Positive

K Health, a startup founded in 2016 as a symptom checking tool, is now deploying its AI chatbot within hospital environments.

The shift follows a broader surge in AI driven virtual doctors that patients can converse with, a trend that has gathered momentum over the past year.

By embedding its chatbot into clinical workflows, K Health hopes to aid clinicians with patient triage and information gathering, though specific deployment details remain limited.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “How K Health moved AI chatbots into hospitals”

read at Endpoints ↗
85 words · retrieved Jun 9
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 12h agoMerck's top dealmaker signals more M&A as Keytruda's patent cliff nearsEndpoints
  • 16h agoNovartis' drug delivery deal with Alteogen; More worker cuts at CellaresEndpoints
  • 16h agoPfizer shares ADC rights with Medicus; RevMed updates lung cancer dataEndpoints
  • 16h agoAbbVie claims Phase 3 win for multiple myeloma drug etentamigEndpoints
  • 17h agoHealth tech investors are looking at bigger betsEndpoints